A multi-epitope vaccine candidate for Mycobacterium tuberculosis demonstrates how immunoinformatics can guide antigen discovery and vaccine development.
doi.org/10.1016/j.dc...
#Tuberculosis #VaccineDesign #Immunoinformatics #PathogenGenomics #TBResearch

Beyond bacilli: integrating the microbiome into the TB research agenda - PubMed Tuberculosis (TB) remains a leading infectious killer, with growing evidence that the human microbiome-particularly in the gut and lungs-shapes susceptibility, progression, and treatment outcomes. Over the past decade, studies have reported that TB-associated dysbiosis, which is more common in the g …

🆕 Novo artigo publicado | New paper
📌 Beyond bacilli: integrating the microbiome into the TB research agenda

pubmed.ncbi.nlm.nih.gov/41778780/
#Tuberculose @TB #TBresearch

Our phenomenal postdoc @Yingli_Shi won the best poster award at CoBRE colloquium. Really proud PI here 🥰!!

@LSUHS @LSUHS_Micro
#newPI #TBresearch #conference #Award

Can TB be detected from the air we breathe out? 🌬️🫁

Yes! This study shows how a small device (THOR) can detect infectious TB cases that sputum tests may miss 🔍

Read more @academic.oup.com: doi.org/10.1093/ofid...

#TB #Tuberculosis #AerosolScience #PublicHealth #TBResearch #InfectiousDiseases #THOR

🔬 TB, infectious disease & global health researchers: Save $250 by registering for the Keystone Symposium on Tuberculosis by Jan 22 (11:59 PM MST). Join leaders in TB biology & global health. 🎥 youtu.be/4L_N79rDCfw
🔗 keysym.us/KSTB26
@maxgg.bsky.social @breealdridge.bsky.social #KSTB26 #TBResearch

Trial of High-Dose Oral Rifampin in Adults with Tuberculous Meningitis.
Aarnoutse, Rob et al.
Paper
Details
#TuberculousMeningitis #RifampinTrial #TBResearch

The 3rd Conference on Innovations in Tuberculosis is back next year!

📅11 May 2026
📍Dar es Salaam, Tanzania

Join us as we explore collaboration, innovation, and region-specific strategies to tackle #TB! 
🔗 https://amededu.co/4iJVMcP

P.S. We’re now accepting abstracts!

#TBResearch #TBSky #IDSky

Proud moment for our team as Honours student Carmen Nhabinde successfully defended her research on gut microbiome changes in drug-resistant TB 🎓🧬

A big congratulations on this important contribution to TB science!

#TBResearch #Microbiome #DrugResistance #CLIME #StellenboschUniversity

🗓️ Workshop #UnionConf2025!
Learn how Beate Ringwald, Mary Mpakibi, Zakariah Abdukkahi, Rebecca Karimu, Chukwuebuka Ugwu, Jasper Nidoi & Rhoda Pola use participatory visual methods to build trust, centre lived TB experiences & foster equitable research partnerships.
#CommunityEngagement #TBResearch

🌍Day 1 of #UnionConf2025!
The global TB community is gathering to share groundbreaking research, innovative tools, and lessons from the field. Let’s show our support for colleagues presenting on TB prevention, treatment, and care worldwide. #TBSky #GlobalHealth #TBResearch

Back from #MycoVLC2025 after presenting our M. tuberculosis work. Huge thanks to Mireia for stellar mentorship. Proud of my @pathogenomics.bsky.social mycolegas for standout posters. Energized to turn ideas into results. #TB #TBResearch @i2sysbio.es

Congratulations to our PhD students Erick Auma & Yonas Ghebrekristos, who both successfully defended their theses in front of national and international reviewers!
Stay tuned, we’ll share more about their innovative research when they officially graduate in December! ✨
#TBResearch #DrugResistance

#CLIME held its latest Community Advisory Board (CAB) meeting. The PREFIT team celebrated enrolling 1500 TB contacts with CAB’s support🎊

Other studies presented their work, and we look forward to continued collaboration 🤝

#TBResearch #CommunityEngagement #GlobalHealth #TBinnovation #EDCTP

Institut für Infektions- und Tropenmedizin

Safer options for #MDRTB: Studies show sutezolid & delpazolid are as effective as linezolid but better tolerated. A milestone for future TB therapy. 👉 www.lmu-klinikum.de/tropeninstitut
#TBResearch #GlobalHealth #DZIF

2 weeks to go! Join the 3-day virtual symposium - The Multiple Syndemics of Tuberculosis from 10–12 Sep.

Explore how TB interacts with other diseases, impacts, and what care approaches are needed.

Register at: forms.office.com/r/2NenfJRJ8R

#Tuberculosis #TBResearch

AI-powered analysis reveals how drugs kill tuberculosis at the molecular level Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five patients have a type of TB that resists these first-line medications. Now, a new study offers a powerful AI-assisted method for uncovering exactly how TB drugs kill the bacteria, opening the door to smarter treatment combinations that could work faster.

Deadly TB battles back—but AI is decoding how drugs *really* kill it! 🔬✨ Could unlock faster cures & rewrite the fight against this ancient foe? #TBresearch

Source: phys.org/news/2025-08-ai-powered-...

The CLIME lab at SU was delighted to host Alaina Olson & Rachel Wood from UW’s Cangelosi Lab.

Their visit focused on tongue swab TB diagnostics, exploring new techniques to improve detection & make testing more accessible.

#TBResearch #GlobalHealth #Diagnostics #Collaboration

Get ready with me to go into the BSL3☣

Each layer of protection has a purpose — from the gloves to the Powered Air-Purifying Respirator (PAPR) — ensuring safety when handling TB cultures🧫

This careful preparation is what makes critical TB research possible.

#GRWM #BSL3 #TBResearch #LabLife

Join the 3-day virtual symposium - The Multiple Syndemics of Tuberculosis from 10–12 Sep 2025.

Explore how TB interacts with other diseases, impacts, and what future screening and care approaches are needed.

Register at: forms.office.com/r/2NenfJRJ8R

#Tuberculosis #GlobalHealth #TBResearch

The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis - npj Antimicrobials and Resistance npj Antimicrobials and Resistance - The Parkinson’s drug benztropine possesses histamine receptor 1-dependent host-directed antimicrobial activity against Mycobacterium tuberculosis

New TB research! 🧫 A collab between VIDO & UBC shows the Parkinson’s drug benztropine may help immune cells fight TB. VIDO confirmed it works in infected mice using our CL3 labs. Great example of shared expertise in action.
🔗 www.nature.com/articles/s44...
#TBResearch #ScienceCollaboration

4 people standing in a semi circle smiling and looking towards the camera. sign in the middle stating 'national tuberculoisis & leprosy control programme (NTBLCP) Federal Ministry of Health'

📊 Supporting data-driven TB response in Nigeria

Vibol Iem from the LIGHT programme worked with NTBLCP & Zankli Research Center to analyze TB data through the lens of poverty, gender & education. Paving the way for equity-focused, gender-responsive action.

#TBResearch #EndTB #HealthEquity #Nigeria

Diana Aguilar from @unizar.es presented at #ASMMicrobe on June 22, on behalf of the ERA4TB consortium.
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.

#TBSky #TBResearch #DrugDevelopment

Programme | ESM

Let's go Lisbon! #ESM2025 starts now. Ready for a week of groundbreaking mycobacteriology?

See the full schedule: www.esmycobacteriology.eu/event-progra...

#Science #TBResearch

Lara V from ERA4TB partner @uc3m.es is attending the 38th IEEE International Symposium on Computer-Based Medical Systems, held in Madrid. Lara was presenting on ‘Detection of active and latent tuberculosis with explainable deep learning ensembles’ along with her colleagues.

#TBSky #TBResearch

Mapping tuberculosis prevalence in Africa using a Bayesian geospatial analysis - Communications Medicine Liyew et al. predict the subnational and local-level prevalence of tuberculosis (TB) in Africa. The findings reveal significant variations in TB prevalence across different local areas.

NEW RESEARCH!

Liyew et al. predict subnational and local-level tuberculosis (TB) in Africa revealing diverse prevalence across different local areas.

https://bit.ly/45Wi46D





#Tuberculosis #TBResearch #HealthAfrica #GlobalHealth #Epidemiology #GeospatialHealth

🎉 Congratulations to Dr Bih Chendi on two incredible achievements🎖️
Read more about her journey and what these milestones mean on our blog (🔗 in bio)
 
#WomenInScience #TBResearch #ResearchExcellence #DOI #BMRI #ChegouLab #VALIDATE #Fellowship #Achievement #ProudMoment #StellenboschUniversity

Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials - PubMed Tuberculosis drug trials are primarily designed to identify antibiotic regimens with the strongest potency to kill <i>Mycobacterium tuberculosis</i>. However, microbiologic cure is not synonymous…

🚨 Publication Alert🚨
TB treatment trials often focus on antibiotics, but microbiological clearance doesn't guarantee better health. It's crucial to consider lung function, heart health, and cancer risk with antimicrobial success. buff.ly/UlxT3sm
Congrats to all contributors👏
#tbresearch #biomarkers

Good luck to all the ERA4TB consortium members presenting at PAGE 2025 this week.

www.page-meeting.org/default.asp?...

#TBSky #TBResearch #Tuberculosis

TB and diabetes in Eswatini: Addressing suboptimal treatment outcomes through integrated services Tuberculosis (TB) remains a significant public health challenge in Eswatini, a country with the highest global HIV prevalence. Diabetes mellitus (DM) is increasingly common among people newly…

🚨Publication Alert🚨
The DETECT study utilized various methods to evaluate diabetes mellitus prevalence and its effect on TB treatment outcomes in Eswatini while identifying challenges and enablers for integrating services. #PublicHealth #TBResearch buff.ly/93wSsJS
Congrats to all contributors 👏

📅 3rd June 2025

Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.

➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...

#Tuberculosis #TBResearch #TBSky